Stock EQ EQUILLIUM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Equillium, Inc.

Equities

EQ

US29446K1060

Delayed Nasdaq
Other stock markets
 12:34:24 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.65 USD -3.51% Intraday chart for Equillium, Inc. 0.00% +128.22%
Apr. 02 H.C. Wainwright Adjusts Price Target on Equillium to $5 From $4, Keeps Buy Rating MT
Apr. 01 Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1B Equalise Study of Itolizumab in Lupus Nephritis CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Equillium, Inc. Promotes Maple Fung to the Position of Chief Medical Officer
CI
Equillium, Inc. Appoints Preston Klassen Board of Directors
CI
Equillium, Inc. Appoints Barbara Troupin to its Board of Directors and as Member of Nominating and Corporate Governance Committee
CI
Equillium Acquires Biotechnology Company Bioniz Therapeutics
MT
Equillium, Inc. Announces Cessation of Dolca Thomas as Executive Vice President of Research & Development and Chief Medical Officer
CI
Equillium, Inc. Appoints Yu Xu, Ph.D., as A Class II Director
CI
Equillium, Inc. Appoints Dolca Thomas as Executive Vice President of Research & Development and Chief Medical Officer, Effective January 11, 2021
CI
Equillium, Inc. Announces Executive Changes
CI
Equillium, Inc. Announces Executive Changes
CI
Equillium, Inc. Announces Executive Changes
CI
Equillium Expands Scientific and Clinical Advisory Team
CI
Equillium, Inc. Announces Executive Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EQ Stock
  4. News Equillium, Inc.
  5. Insiders